SAN DIEGO, CA--(Marketwire - February 09, 2009) - Bayer Technology Services GmbH (BTS) together with Accelrys, Inc. (NASDAQ: ACCL) today announced that BTS has chosen Accelrys as their partner in the area of Materials Modeling and Simulation. BTS gains access to Accelrys’ complete range of modeling and simulation tools including Materials Studio® 4.4, the newest version of Accelrys’ multiscale modeling and simulation platform.
BTS has selected Accelrys as a partner due to the breadth and depth of its Materials Studio solution. Materials Studio extends the capabilities that have been limiting researchers in solving real-world problems.
The agreement forms part of a strategic innovation initiative at BTS providing services as well engaging in a range of academic collaborations.
“We are very excited about our joint partnership with Bayer on their upcoming projects and providing them with a complete multiscale modeling environment, Materials Studio, which helps them to create flexible, customizable and integrated solutions,” said Accelrys’ President and Chief Executive Officer Todd Johnson.
We are pleased about this collaborative relationship with Accelrys since we believe their Materials Modeling and Simulation products will be instrumental in creating flexible, customizable and integrated solutions that will help us solve key problems throughout the research and development process,” said Dr. Helmut Mothes, Senior Vice President and Head of Process Technology of Bayer Technology Services.
For more information about Materials Studio or to download a free trial of the visualization component, Materials Visualizer, please visit http://accelrys.com/.
About Bayer Technology Services:
Bayer Technology Services GmbH offers fully-integrated solutions along the life cycle of chemical/pharmaceutical plants -- from development through engineering and construction to process optimization for existing plants. The Bayer subsidiary employs nearly 2,600 experts worldwide at its headquarters in Leverkusen and other German locations, as well as in regional offices in Baytown, Texas, USA; Antwerp, Belgium; Mexico City, Mexico; and Shanghai, People’s Republic of China. 2007 sales totaled approximately EUR 400 million. Additional information about Bayer Technology Services is available at www.bayertechnology.com.
About Accelrys, Inc.
Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Our customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. We have a vast portfolio of computer-aided design modeling and simulation offerings which assist our customers in conducting scientific experiments ‘in silico’ in order to reduce the duration and cost of discovering and developing new drugs and materials. Our scientific business intelligence platform underlies most of our computer-aided design modeling and simulation offerings. Our platform can be used with our products, our competitors’ products and our customers’ proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable our customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, visit its website at http://accelrys.com/.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Forward-Looking Statements
This press release contains forward-looking statements. Such statements, including statements relating to the partnership agreement, revenue stream resulting therefrom, other similar agreements, Materials Studio, its features and potential demand therefore, are subject to risks and uncertainties including, but not limited to, the risks that the partnership and Materials Studio will not successfully achieve market acceptance, demand relating to Materials Studio, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Digg this 
Bookmark with del.icio.us 
Add to Newsvine
Technorati: materials studio multi scale modeling modeling and simulation accelrys bayer
